Document is current
Any future updates will be listed below
-
Authors
Müller-Reif, Johannes B. https://orcid.org/0000-0003-3454-2396
Albrecht, Vincent https://orcid.org/0009-0003-1985-7733
Brennsteiner, Vincenth
Bader, Jakob M. https://orcid.org/0000-0002-6575-0609
Treit, Peter V. https://orcid.org/0000-0002-5264-5877
Wewer Albrechtsen, Nicolai J. https://orcid.org/0000-0003-4230-5753
Pangratz-Führer, Susanne https://orcid.org/0000-0002-5846-9675
Mann, Matthias https://orcid.org/0000-0003-1292-4799
-
Funding
Funding for this research was provided by:
Max-Planck-Gesellschaft
Novo Nordisk Fonden (NNF14CC0001)
Novo Nordisk Fonden (NNF15CC0001)
- License Information
-
More Information
Article History
Received: 2 May 2025
Accepted: 12 December 2025
First Online: 27 January 2026
Competing interests
: MM is an indirect shareholder of Evosep. All other authors declare no competing interests.
